U.S. market projected at USD 0.91 billion and Europe at USD 0.76 billion by 2035, driven by cancer diagnostics, PET-CT/PET-MRI adoption, and advanced molecular imaging
U.S. market projected at USD 0.91 billion and Europe at USD 0.76 billion by 2035, driven by cancer diagnostics, PET-CT/PET-MRI adoption, and advanced molecular imaging